Literature DB >> 26806404

Effects of adenosine metabolism in astrocytes on central nervous system oxygen toxicity.

Yu-liang Chen1, Ya-nan Zhang2, Zhong-zhuang Wang3, Wei-gang Xu2, Run-ping Li4, Jun-dong Zhang5.   

Abstract

Hyperbaric oxygen (HBO) is widely used in military operations, especially underwater missions. However, prolonged and continuous inhalation of HBO can cause central nervous system oxygen toxicity (CNS-OT), which greatly limits HBO's application. The regulation of astrocytes to the metabolism of adenosine is involved in epilepsy. In our study, we aimed to observe the effects of HBO exposure on the metabolism of adenosine in the brain. Furthermore, we aimed to confirm the possible mechanism underlying adenosine's mediation of the CNS-OT. Firstly, anesthetized rats exposed to 5 atm absolute HBO for 80 min. The concentrations of extracellular adenosine, ATP, ADP, and AMP were detected. Secondly, free-moving rats were exposed to HBO at the same pressure for 20 min, and the activities of 5'-nucleotidase and ADK in brain tissues were measured. For the mechanism studies, we observed the effects of a series of different doses of drugs related to adenosine metabolism on the latency of CNS-OT. Results showed HBO exposure could increase adenosine content by inhibiting ADK activity and improving 5'-nucleotidase activity. And adenosine metabolism during HBO exposure may be a protective response against HBO-induced CNS-OT. Moreover, the improvement of adenosine concentration, activation of adenosine A1R, or suppression of ADK and adenosine A2AR, which are involved in the prevention of HBO-induced CNS-OT. This is the first study to demonstrate HBO exposure regulated adenosine metabolism in the brain. Adenosine metabolism and adenosine receptors are related to HBO-induced CNS-OT development. These results will provide new potential targets for the termination or the attenuation of CNS-OT.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenosine; Adenosine receptor; Astrocytes; Central nervous system oxygen toxicity; Hyperbaric oxygen

Mesh:

Substances:

Year:  2016        PMID: 26806404     DOI: 10.1016/j.brainres.2016.01.026

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Audit of practice in Australasian hyperbaric units on the incidence of central nervous system oxygen toxicity.

Authors:  Susannah Sherlock; Mandy Way; Alexis Tabah
Journal:  Diving Hyperb Med       Date:  2018-06-30       Impact factor: 0.887

Review 2.  Adenosine Kinase on Deoxyribonucleic Acid Methylation: Adenosine Receptor-Independent Pathway in Cancer Therapy.

Authors:  Hao-Yun Luo; Hai-Ying Shen; R Serene Perkins; Ya-Xu Wang
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

3.  Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.

Authors:  Zhenyu Luo; Hao Tian; Lanlan Liu; Zhikuan Chen; Ruijing Liang; Ze Chen; Zhihao Wu; Aiqing Ma; Mingbin Zheng; Lintao Cai
Journal:  Theranostics       Date:  2018-06-07       Impact factor: 11.556

4.  Oxygenating the way for enhanced chemophototherapy.

Authors:  Wen Jiang; Ian Michael Delahunty; Jin Xie
Journal:  Theranostics       Date:  2018-06-21       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.